National Healthcare Stock Performance
| NHC Stock | USD 103.61 0.19 0.18% |
On a scale of 0 to 100, National HealthCare holds a performance score of 11. The company secures a Beta (Market Risk) of 0.98, which conveys possible diversification benefits within a given portfolio. National HealthCare returns are very sensitive to returns on the market. As the market goes up or down, National HealthCare is expected to follow. Please check National HealthCare's skewness, day typical price, and the relationship between the downside variance and daily balance of power , to make a quick decision on whether National HealthCare's current price movements will revert.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in National HealthCare are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile technical indicators, National HealthCare exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.18 | Five Day Return (0.37) | Year To Date Return 11.12 | Ten Year Return 91.48 | All Time Return 6 K |
Forward Dividend Yield 0.0239 | Payout Ratio 0.4518 | Forward Dividend Rate 2.44 | Dividend Date 2024-08-01 | Ex Dividend Date 2024-06-28 |
1 | Returns On Capital Are A Standout For New Hope | 03/19/2024 |
2 | Looking for an ASX growth share Try the Pilbara Minerals Ltd share price | 04/10/2024 |
3 | Whats driving New Hope shares gigantic 8.4 percent dividend yield | 04/29/2024 |
| National HealthCare dividend paid on 1st of May 2024 | 05/01/2024 |
4 | Disposition of 7500 shares by W Adams of National HealthCare at 77.92 subject to Rule 16b-3 | 05/07/2024 |
5 | NHC Announces 3.4 percent Increase in Common Dividend | 05/09/2024 |
6 | National Healthcare reports Q1 results | 05/10/2024 |
7 | Monsters of Rock The Alpha of HPA and gold deals as little miners emerge on the radar | 05/20/2024 |
8 | Guess which ASX 200 mining giant could crash 30 | 05/22/2024 |
9 | NHC to Acquire White Oak Senior Living Portfolio | 06/03/2024 |
10 | Acquisition by Leroy McIntosh of 3733 shares of National HealthCare at 53.94 subject to Rule 16b-3 | 06/11/2024 |
| Begin Period Cash Flow | 73.8 M |
National |
National HealthCare Relative Risk vs. Return Landscape
If you would invest 9,167 in National HealthCare on March 15, 2024 and sell it today you would earn a total of 1,194 from holding National HealthCare or generate 13.02% return on investment over 90 days. National HealthCare is generating 0.2067% of daily returns assuming volatility of 1.3575% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than National, and above 96% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
National HealthCare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for National HealthCare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as National HealthCare, and traders can use it to determine the average amount a National HealthCare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1523
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NHC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.36 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average National HealthCare is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of National HealthCare by adding it to a well-diversified portfolio.
National HealthCare Fundamentals Growth
National Stock prices reflect investors' perceptions of the future prospects and financial health of National HealthCare, and National HealthCare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on National Stock performance.
| Return On Equity | 0.0889 | ||||
| Return On Asset | 0.0275 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 1.46 B | ||||
| Shares Outstanding | 15.4 M | ||||
| Price To Earning | 22.85 X | ||||
| Price To Book | 1.51 X | ||||
| Price To Sales | 1.21 X | ||||
| Revenue | 1.12 B | ||||
| Gross Profit | 388.11 M | ||||
| EBITDA | 87.99 M | ||||
| Net Income | 66.8 M | ||||
| Cash And Equivalents | 58.67 M | ||||
| Cash Per Share | 14.19 X | ||||
| Total Debt | 93.39 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 1.76 X | ||||
| Book Value Per Share | 60.05 X | ||||
| Cash Flow From Operations | 111.22 M | ||||
| Earnings Per Share | 5.33 X | ||||
| Market Capitalization | 1.63 B | ||||
| Total Asset | 1.31 B | ||||
| Retained Earnings | 687.6 M | ||||
| Working Capital | 191.76 M | ||||
| Current Asset | 164.61 M | ||||
| Current Liabilities | 114.08 M | ||||
About National HealthCare Performance
To evaluate National HealthCare Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when National HealthCare generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare National Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand National HealthCare market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents National's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 7.86 | 9.92 | |
| Return On Tangible Assets | 0.06 | 0.06 | |
| Return On Capital Employed | 0.04 | 0.04 | |
| Return On Assets | 0.05 | 0.06 | |
| Return On Equity | 0.07 | 0.07 |
Things to note about National HealthCare performance evaluation
Checking the ongoing alerts about National HealthCare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for National HealthCare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 56.0% of the company shares are owned by institutional investors | |
| On 1st of May 2024 National HealthCare paid $ 0.59 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Acquisition by Leroy McIntosh of 3733 shares of National HealthCare at 53.94 subject to Rule 16b-3 |
- Analyzing National HealthCare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether National HealthCare's stock is overvalued or undervalued compared to its peers.
- Examining National HealthCare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating National HealthCare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of National HealthCare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of National HealthCare's stock. These opinions can provide insight into National HealthCare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for National Stock analysis
When running National HealthCare's price analysis, check to measure National HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National HealthCare is operating at the current time. Most of National HealthCare's value examination focuses on studying past and present price action to predict the probability of National HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National HealthCare's price. Additionally, you may evaluate how the addition of National HealthCare to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |